Novo Nordisk (NVO) closed the most recent trading day at $50.29, moving +2.53% from the previous trading session. The stock outpaced the S&P 500's daily gain of 0.21%. Elsewhere, the Dow gained 1.35%, while the tech-heavy Nasdaq lost 0.26%. Shares of the drugmaker have depreciated by 2.41% over the course of the past month, underperforming the Medical sector's gain of 3.7%, and the S&P 500's gain of 0.89%.The upcoming earnings release of Novo Nordisk will be of great interest to investors. On that day, Novo ...